21GRAMS

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

21GRAMS - overview

Established

2018

Location

New York, NY, US

Primary Industry

Marketing/Advertising

About

21GRAMS is a healthcare marketing firm that specializes in creating innovative strategies to connect brands with their target audiences through engaging storytelling and tailored digital marketing solutions. Founded in 2018, 21GRAMS operates from New York, US, providing strategic marketing services specifically for the healthcare sector. In January 2020, the company was acquired by W2O Group, a portfolio company of New Mountain Capital, though specific financial terms were not disclosed. The founder's history is not available but the firm has successfully completed 1 deal by the most recent deal date.


21GRAMS offers a unique approach to healthcare marketing, focusing on developing innovative strategies that connect brands with their audiences through storytelling and engagement. Their primary services include brand strategy, creative development, and digital marketing tailored specifically for the healthcare sector. By leveraging data-driven insights, the company aims to address the complexities of healthcare communication, ensuring that brands resonate with both healthcare professionals and patients. Their clientele spans various segments of the healthcare industry, including pharmaceutical companies, medical device manufacturers, and healthcare service providers, primarily in North America and Europe.


The company's approach emphasizes building meaningful relationships through their services, which have evolved to meet the changing demands of this dynamic market. 21GRAMS generates revenue through a combination of project-based engagements and retainer agreements with its clients in the healthcare space. The firm engages in B2B transactions, partnering with healthcare brands to deliver customized marketing solutions that address specific challenges within the industry. These partnerships often involve long-term contracts that enable clients to access a suite of services, such as ongoing brand management, campaign execution, and analytics reporting.


The pricing structure is designed to be flexible, accommodating various client needs based on the scope and duration of services rendered. Flagship offerings may include comprehensive marketing campaigns that combine digital outreach with strategic consulting, ensuring that clients can effectively engage their target audiences. Following its acquisition in January 2020, 21GRAMS is poised for expansion within the healthcare marketing sector. While specific upcoming products have not been detailed, the company aims to leverage its new resources to enhance its service offerings and explore additional markets.


Targeted geographic regions for expansion are not explicitly stated, but the firm is likely to continue its focus on North America and Europe, capitalizing on the increased demand for healthcare communication strategies. The recent acquisition will support these initiatives by providing access to a broader client base and enhanced operational capabilities.


Current Investors

Real Chemistry

Primary Industry

Marketing/Advertising

Sub Industries

Advertising Agencies & Media Buyers

Website

www.21gramsny.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

21GRAMS - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompleted21GRAMS-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.